Dissertation > Excellent graduate degree dissertation topics show

Study on the Different Biological Characteristics of CD133~+ Cells and CD133~- Cells in Renal Cell Carcinoma

Author: SongJunYan
Tutor: YueZhongZuo
School: Lanzhou University
Course: Surgery
Keywords: CD133 Renal cell carcinoma Cancer stem cells Tumor-initiating cells Stem / progenitor cells
CLC: R737.11
Type: Master's thesis
Year: 2008
Downloads: 120
Quote: 0
Read: Download Dissertation


Objective: human CD133 (Human prominin-1 PROM-1) were identified in the different tissues of stem / progenitor cells or cancer stem cells (tumor initiating cells) (cancer stem cells, tumor-initiating cells) markers. The purpose of this paper is to study compared human renal carcinoma cell line 786-0 and OS-RC-2 medium of CD133 cells and CD133 - differences in the biological characteristics of the cells. Methods: application of flow cytometry renal carcinoma cell line 786-0 and OS-RC-2 in the membrane of CD133 expression status; immunomagnetic beads of CD133 of of cells and CD133 - < / sup> cell separation and purification, both in the light microscope morphology, growth characteristics, proliferation capacity, long-term ability to differentiate in vitro cloning formation rate differences; Flow cytometric analysis of cell cycle distribution between changes, using the MTT sensitivity difference in law between the two chemotherapy drug cisplatin (DDP). Results :786-0 and OS-RC-2 in both CD133 expression of a small amount of (8.12 ± 0.86)% and (6.83 ± 0.20)% cells of CD133 of CD133 compared - cells has a strong in vitro proliferation, colony formation and long-term ability to differentiate; the the 786-0 in of CD133 cells, of CD133 , - cells and unsorted cell population doubling time, respectively, 19.46h, 22.03h, 20.03h: OS-RC-2 medium of CD133 cells, CD133 - cells and unsorted cell population doubling time was 18.84h, 22.26 h, 21.18h; the 786-0 and OS-RC-2 in of CD133 cell colony formation rate (38.47 ± 4.27)% and (32.47 ± 5.21)% of CD133 - cell colony formation rate (21.38 ± 3.58)% and (26.04 ± 7.12)%, respectively; cells 786-0 in CD133 cells, CD133 - G 0 / G 1 , respectively (65.77 ± 0.81)% and (44.9 ± 2.21)% in S phase (13.65 ± 0.42)%, (39.66 ± 1.25)%, G 2 / M% of (10.83 ± 0.35), (12.24 ± 0.31)%, OS-RC-2 of CD133 cells of CD133 - cells G 0 / G 1 Phase (61.58 ± 1.32)% and (42.3 ± 3.11)% S phase (12.17 ± 0.22)%, respectively, (37.80 ± 0.32)%, the G 2 / M, respectively (11.36 ± 0.22)%, (16.23 ± 0.36)%, CD133 by cells, CD133 - compared to cells both were significant differences statistically significant (P <0.01). MTT assay showed that CD133 cells, CD133 - cells no statistically significant difference in sensitivity to DDP. Conclusions: confirmed renal cancer cell lines of CD133 cells have some of the characteristics of the kidney cancer stem cells, can be used as surface markers of kidney cancer stem cells further experiments need to be made clear.

Related Dissertations

  1. The Effects of Aspirin on Tumor-related Markers of Stem Cell in the Human Colon Cancer Cell Line HT-29 and SW-480,R735.35
  2. Sorafenib Treatment of Advanced Kidney Cancer Efficacy and Safety Evaluation,R737.11
  3. Fundamental Research of the Function of Angiogenesis Inhibitors to Colon Cancer Stem Cells in Mice and Analysis of Related Mechanism,R735.35
  4. The Expression and Clinical Significance of EpCAMhigh /CD44+ Colorectal Cancer Stem Cells and β-catenin in Colorectal Cancer,R735.34
  5. The in Vitro Study of Serum-free Culture Combined DDP Enriching Human Lung Cancer Stem Cells,R734.2
  6. Low- dose cisplatin liver cancer stem cells enriched experimental study,R735.7
  7. SIRNA interfere with transcription factor SOX2 and OCT4 on the proliferation of cancer stem cells,R735.2
  8. Expression and Clinical Significance of HIF-1α, HIF-3α in Renal Cell Carcinoma,R737.11
  9. Culture of Spheres from Pancreatic Cancer Cells and Study of Biological Characteristics,R735.9
  10. Expression of EGFR and ADAM9 in Pancreatic Cancer Panc-1 Cell Spheres,R735.9
  11. Single-chain antibody phage display EpCAM targeting Preparation and preliminary study of lung adenocarcinoma cells,R734.2
  12. Radical Nephrectomy Renal Cell Carcinoma Treated with IFN-α Graduate Clinical Research,R737.11
  13. Results and Follow-up of Laparoscopic and Open Partial Nephrectomy in Local Renal Cell Carcinoma,R737.11
  14. High Efficacy Transduction Hybrid AAV Vector and Its Application in β-thalassemia Gene Therapy Research,R556.61
  15. Initial Study of CD133 As One of Surface Markers in Hepatocellular Carcinoma Stem Cell,R735.7
  16. The Expression of Musashi-1 (intestinal Stem/progenitor Marker) in Clonic Cancer,R735.3
  17. The Expression of Survivin and VEGF in Renal Cell Carcinoma and Their Clinical Significance,R737.11
  18. The Study of Fe3O4 Nanoparticles Labeled Breast Cancer Stem Cells and the Influence to Their Biological Characteristics,R737.9
  19. Experiment on Cultivation and Identification of Colorectal Cancer Stem Cell-derived Spheres in Vivo and in Vitro,R735.34
  20. In Vitro Chemosensitivity Testing of BGSCs on Chemotherapy Agents,R739.4
  21. Expression and Significance of OCT4 in Bladder Cancer,R737.14

CLC: > Medicine, health > Oncology > Genitourinary tumors > Urinary tumors > Kidney,renal pelvis tumor
© 2012 www.DissertationTopic.Net  Mobile